SRPT earnings: a positive outcome, +6.1%

On November 3, 2021, Sarepta Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.1% in the window around the event. It had already run -16.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.